5. Page 5
Role of cancellous bone
• Scaffold where cells interact
• Nutrition
• Hematopoiesis, Myelogenesis, Platelet
formation
• Source of pluripotent osteoprogenitor stem
cell
• Local growth factors for differentiation
• Same strength of cortical bone by 6-12
months
6. Page 6
General characteristics of successful
bone graft
Osteogenesis
Osteoinduction
Osteoconduction
Good handling characteristic
Non toxic
Biomechanical property similar to cancellous
bone
7. Page 7
Osteogenesis
Process of bone formation through cellular
osteoblastic activity which depends on the
presence of osteoprogenitor stem cells.
14. Page 14
Major complications
• Infection
• Prolonged wound
drainage
• Hernia
• Deep hematoma
• Need for reoperation
• Pain > 6 months
• Profound sensory
loss
• Heterotopic bone
formation
• Vascular injury
• Neurologic injury
• Scars
• Subluxation
• Gait disturbance
• SI destabilization
• Enterocutaneous
fistula
• Pelvic fracture
15. Page 15
• 3cm – distance from donor site and ASIS /
PSIS
• 3cm – maximum distance from dorsal
ilium
16. Page 16
Factors which can’t be avoided
• Increased operative time
• Blood loss
• Donor site – pain
• Cosmetic defect
17. Page 17
Sites
• Iliac crest (Anterior or posterior iliac crest)
• Greater trochanter
• Gerdy's tubercle
• Distal part of the radius
• Distal part of the tibia
18. Page 18
• Autogenous cancellous bone graft is an excellent choice
for nonunions with <5 to 6 cm of bone loss and that
do not require structural integrity from the graft. It can
also be used to fill bone cysts or bone voids after
reduction of depressed articular surfaces such as in a
tibial plateau fracture. Stable internal or external
fixation is also required, to provide the optimum
environment for graft consolidation and successful
fracture-healing.
20. Page 20
• With or without vascular pedicle
• Osteoconduction + Osteogenesis
• Non vascularized grafts become weaker in
6 weeks – resorption, revascularization
• Vascularized – stronger – remodelling
similar to normal bone
• But by 6-12 months – no difference
• Fixation required
21. Page 21
• Advantage
• Defects > 5-6cm
• Immediate structural
support
• Disadvantage
• Subjective sense of
weakness and
instability
• Big toe weakness
• Need for reoperation
at donor site
22. Page 22
Osteoconductive matrices
• No osteogenic or osteoinductive property
• Greater source availability
• Elimination of second operative site
• Tricalcium phosphate (alpha, beta)
• Hydroxyapatite
• Injectable calcium phosphate cement
24. Page 24
Allograft
• Surge in popularity – increased availability
donor screening and
tissue processing for safety
new forms has
increased versatility
25. Page 25
• Machine tooling to shape structural
allograft
• Reduction of procurement morbidity
• Potential for immediate structural support
• Reasonable success (60-90%)
26. Page 26
Allograft - ConA
• Results inferior to autograft
• Vary in initial bone quality
• Expensive
• Disease transmission
• Immunogenic reaction
27. Page 27
• Processing – its disadvantage
• Slower resorption
• Not completely replaced by new bone
• Reduced structural integrity
• Poor results in lumbar fusion
31. Page 31
Demineralized bone matrix
• Allograft bone that has had the inorganic
mineral removed, leaving behind the
organic collagen matrix
• More osteoinductive properties
• DBM + glycerol carrier – commonly used
• Available data – more as bone graft
extender, not substitute
36. Page 36
Xenograft
• From animals
• Impractical for clinical use on a wide scale
• Removal of protein and fat – processing
• Removes osteoinductive proteins
• Kiel bone, Oswestry, Bio Oss
37. Page 37
Ceramics
• Stable compounds of metals with oxygen
or other anions
• Non injectable ceramics – according to
resorbing power
• Injectable ceramics
38. Page 38
Non injectable ceramics
• Osteoconductive
• Hydroxyapatite, Tricalcium phosphate,
Calcium sulphate dihydrate
• High quality synthetic material with no
biologic hazards
39. Page 39
• Alternative or as an addition to either
cancellous autograft or allograft or as a
cancellous bone void filler or bone graft
extender or in sites where compression is
the dominant mode of mechanical loading
• Safe and effective substitute for iliac graft
autograft
• Cost
41. Page 41
Rapidly resorbing ceramics
• Tricalcium phosphate (alpha 1200
degrees, beta at 800 degrees) – 39% Ca,
20% P
• Calcium sulfate
42. Page 42
• Calcium phosphate – calcium phosphate
rich microenvironments that stimulate
osteoclastic resorption and then
osteoblastic new bone formation, resulting
in new bone formation
• Pore size - less porous formulations
resorb before complete bone ingrowth
43. Page 43
• Calcium sulfate - Osteoconductive but its
rapid resorption rate creates doubt about
its ability to maintain a three-dimensional
framework to support Osteogenesis
44. Page 44
Intermediate resorbing ceramic
• Beta tricalcium phosphate - In the process
of being resorbed, it can enrich the local
environment with osteogenic substrates
that, in turn, can be used by activated
osteoblasts
• Broad range of pore size (<1µm to
1000µm)
• Sponge-like interconnected microporosity
endowed with excellent wicking and
hydrophilic properties
46. Page 46
Injectable ceramics
• Calcium phosphate cement - paste of
inorganic calcium and phosphate that
hardens in situ with a low exothermic
temperature
• Slowly transforms into bone over 3 to 4
years
• Adjunct to fixation in both femoral neck
and intertrochanteric hip fractures
48. Page 48
Collagen
• Animal-derived collagen with synthetic
calcium phosphate
• Putty-like consistency
• Can be used as bone graft extenders to
increase the volume of bone graft into a
defect when a sufficient volume of
autograft is not readily available
49. Page 49
Non biologic Osteoconductive
substrates
1. absolute control of the final structure
2. no immunogenicity
3. excellent biocompatibility
Degradable polymers - polylactides
Bioactive glasses
Porous metals - tantalum
51. Page 51
Composite graft
• Any combination of materials that includes
both an osteoconductive matrix and an
osteogenic or osteoinductive material
1.Bone marrow aspirate
2.Osteoblastic progenitor stem cell
3.Blood
4.Platelet rich plasma
5.Growth factors
52. Page 52
Bone marrow aspirate
background
• Osteoblast progenitor cells – 1.periosteum
of long bones 2.the peritrabecular
connective tissue 3.the bone marrow
• All the critical cellular components that
contribute to bone growth present
• Fibroblast, undifferentiated cells
• Animal research suggests that precursor
cells in bone marrow proliferate and
differentiate after transplantation
53. Page 53
• Availability and the relative safety of its
harvest
• Harvested by aspiration from patients, with
limited dilution by peripheral blood
• Concentration
• Culture
54. Page 54
Bone composite
• Used successfully to stimulate healing in
tibial fractures
• Osteogenic potential was maintained as
the cells were expanded in culture
• Facilitated greater bone formation and
fusion success rates
• Xenograft bone and other bone
substitutes could be rendered osteogenic
55. Page 55
Synthetic composite
• Addition of BMA was essential for
tricalcium phosphate and hydroxyapatite
to achieve results comparable to those
obtained with cancellous bone at 24
weeks
• β-TCP/BMA composite may be superior
even to autograft, which suffers from
anoxic cell death in the center of the graft
because of the absence of vascularization
Because separation of body tissue from its blood supply results in cell death
Depends on age sex health genetic predisposition
Pain – more bone removal SI joint destabilization
Vascular – superior gluteal vessels close to sciatic notch
Neurologic sciatic lateral cut nerve
TCP tricalcium phosphate
BMA bone marrow aspirate
Wedges or threaded bone – function both as graft and fixation device
Destroys osteoinductive proteins
Less representative of human tissue
Age sex health genetic predisposition
Enhanced bioavailability following demineralization
immunogenecity
Same elemental and stoichiometric properties
facilitate the migration of bone-forming cells, growth factors, and phagocytic cells into it, enhancing the process of new bone development and its resorption.
modulate physical properties of bone-filling agents and to deliver factors that stimulate bone formation
facilitates handling and placement at the time of surgery
osteoblasts, adipose cells, chondroblasts, and fibroblasts
the number of progenitors available in a graft site can be increased by concentration
subsequent use in transplantation, stem cells also can be cultured and expanded to many times their original number.
renewable and reliable source of osteogenic cells without the disadvantages of standard open-grafting techniques